Objective:Benign prostatic hyperplasia(BPH)is a common urological disease in older men,and its incidence increases with age.At present,the main treatment is drug and/or surgery.Transurethral vaporization resection of prostate(TUVRP)is a new method for treating BPH.This article mainly compares the therapeutic effect and safety of TUVRP in the treatment of different prostatic hyperplasia(less than 80 ml,more than 80ml),evaluates the effect of this treatment on BPH,and provides more clinical data for surgical treatment of benign prostatic hyperplasia.Method:The case was derived from 398 cases of BPH patients treated with TUVRP treated in our hospital from January 2016 to December 2017.After exclusion according to the screening criteria,280 cases were screened and divided into groups A and B according to prostate volume.Group A prostatic hyperplasia volume For more than 80 ml,the prostatic hyperplasia volume of group B was less than 80 ml,132 patients in group A,and 148 patients in group B.The clinical data of the two groups and the clinical situation of the intraoperative and postoperative cases were statistically analyzed,such as preoperative prostate volume,preoperative international prostate symptom score(IPSS),serum prostate specific antigen(Prostate specific antigen,PSA),Quality of life(QoL),Maximum flow rate(Qmax),and Postvoid residual volume(PRV),as well as operative time,intraoperative blood loss,postoperative Washing time,catheter indwelling time,hospitalization time,and changes in IPSS score,QoL score,Qmax,and PRV before and after treatment.Results:The preoperative prostate hyperplasia volume was A(101.35±12.19)ml and B(61.28±5.01)ml(P=0.0001).Patients in group A had preoperative PSA(4.05±0.96)ng/ml,and group B had preoperative PSA(4.01±1.41)ng/ml.There was no significant difference between the two groups.There were no significant differences in the operation time,bleeding volume,rinsing time,catheter indwelling time,hospitalization time,etc.between the A and B groups in the A and B groups.Preoperative and postoperative comparisons are:For the preoperative IPSS comparison of the two groups of patients,the scores of the 2,4,and 7 items in Table 1 were added as the stimulation symptom score(IPSS1),and the scores of 1,3,5,and 6 were added as the obstructive symptoms.Score(IPSS2),group A,IPSS,IPSS1,IPSS2 score,QoL score,Qmax,PRV were preoperative(21.61±6.82),(10.98±3.19),(13.03±4.84),(4.83±1.01),(11.23±2.01)ml/s,(45.18±13.84)ml improved to postoperative(6.15±3.73),(4.61±3.81),(7.53±2.09),(2.39±0.93)ng/ml,(15.75±2.01)ml/s,(38.18±11.84)ml(P<0.05).In addition,group B IPSS,IPSS1,IPSS2 score,QoL score,Qmax,PRV were preoperative(17.01±6.13),(7.02±3.03),(10.11±4.36),(4.91±1.03),(11.05±2.32).)ml/s,(35.42±13.77)ml improved to postoperative(7.33±4.41),(4.77±3.18),(4.63±1.37)ng/ml,(2.17±0.84),(18.69±2.07)ml/ s,(25.42 ± 12.12)ml(P < 0.05).The difference of QoL score and Qmax between the two groups in group A and group B was statistically significant,and the effect of group B was better than that in group A.Conclusion:Transurethral vaporization resection has a good effect on different types of prostate in the treatment of benign prostatic hyperplasia.Patients with a prostatic hyperplasia volume of less than 80 ml are more advantageous. |